PI3Kδ Inhibition Augments the Efficacy of Rapamycin in Suppressing Proliferation of Epstein−Barr Virus (EBV)+ B Cell Lymphomas

Satoru Furukawa(Astellas Pharma (Japan)), Olivia M. Martinez(Stanford University)

American Journal of Transplantation

July 10, 2013

10.1111/ajt.12328

Cited by 34

Related Papers

Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos

|Journal of Biological Chemistry|2008|46

Src Kinase and Syk Activation Initiate PI3K Signaling by a Chimeric Latent Membrane Protein 1 in Epstein-Barr Virus (EBV)+ B Cell Lymphomas

|PLoS ONE|2012|35

Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders

|Cell Reports Medicine|2024|9